Understanding the Import Prohibition under ART and Surrogacy Acts

The question asks about a significant prohibition imposed by the Indian government in July 2022, linked to the Assisted Reproductive Technology (Regulation) Act, 2021, and The Surrogacy (Regulation) Act, 2021. These acts aim to regulate ART clinics, ART banks, and the practice of surrogacy in India to prevent misuse and ensure ethical practices.

Key Legislation: ART and Surrogacy Acts, 2021

The Indian Parliament enacted these two important laws:

• The Assisted Reproductive Technology (Regulation) Act, 2021: This Act regulates ART services, including gamete donation (sperm or oocyte donation), in vitro fertilization (IVF), intra-cytoplasmic sperm injection (ICSI), and artificial insemination. It mandates registration of ART clinics and banks and sets standards for their operation.
• The Surrogacy (Regulation) Act, 2021: This Act regulates the practice and process of surrogacy in India. It primarily permits altruistic surrogacy (where no monetary compensation beyond medical expenses and insurance is paid to the surrogate mother) and prohibits commercial surrogacy.

Both acts have provisions related to the handling, storage, and transfer of gametes (sperm and eggs) and embryos.

The Prohibition in July 2022

In July 2022, the Directorate General of Foreign Trade (DGFT) issued a notification prohibiting the import of a specific biological material, aligning with the provisions of the newly enacted ART and Surrogacy laws. This prohibition was aimed at regulating cross-border movement of reproductive materials and ensuring that ART procedures and surrogacy adhere to the legal framework within India.

Let's look at the options provided:

• Human embryo: Embryos are created through fertilization and are central to many ART procedures like IVF. Their import could be related to individuals bringing their own embryos created abroad or clinics importing them for patients. Regulation of embryo handling is crucial under both ART and Surrogacy laws.
• Women’s egg: Also known as oocytes, eggs are female gametes. Their import for donation or personal use in ART procedures is also regulated under the ART Act.
• Stem cell: Stem cells are undifferentiated biological cells that can differentiate into specialized cells. While important in medical research and therapy, their import and use are regulated under different guidelines and acts, not primarily the ART or Surrogacy Acts.
• Kidney: Kidneys are organs used for transplantation. Their donation, retrieval, and transplantation are governed by the Transplantation of Human Organs and Tissues Act, 1994, not the ART or Surrogacy Acts.

The specific prohibition announced in July 2022 targeted the import of human embryos. This measure was intended to control the use of embryos within the country's regulatory framework, particularly concerning surrogacy and ART procedures that might involve cross-border movement of genetic material.

Therefore, the import prohibited in July 2022 in line with the ART and Surrogacy Acts, 2021, was that of the human embryo.

Correct Option Analysis

Based on the official notification and the scope of the relevant acts, the prohibition was specifically on the import of human embryos.

• Option 1: Human embryo - This aligns with the prohibition notified in July 2022 under the ambit of the ART and Surrogacy Acts.
• Option 2: Women’s egg - While gametes are regulated, the specific prohibition in July 2022 focused on embryos. Regulations for gamete import might differ or have been implemented separately.
• Option 3: Stem cell - Regulated under different laws.
• Option 4: Kidney - Regulated under different laws (Organ Transplantation Act).

The import of human embryos was prohibited to ensure all ART procedures and surrogacy involving embryos are conducted strictly as per the regulations laid down by the Indian government under the 2021 Acts.

Revision Table: Key Concepts

Additional Information: Scope of ART and Surrogacy Regulation

The 2021 Acts are comprehensive frameworks aiming to address ethical concerns, potential exploitation, and health risks associated with ART and surrogacy services. Beyond regulating clinics and procedures, they also touch upon aspects like:

• Eligibility criteria for individuals seeking ART services or surrogacy.
• Rights of children born through ART or surrogacy.
• Storage limits for gametes and embryos.
• Composition and functions of regulatory bodies at national and state levels.
• Penalties for violations of the Act's provisions.

The prohibition on the import of human embryos is one specific measure under this larger regulatory umbrella, designed to bring all relevant activities under Indian jurisdiction and oversight.